Thema: CH0334081137
CRSP, CH0334081137
securities-and-exchange-7499697_1920.jpg - Foto: THN
CRISPR Therapeutics stock heads to Jefferies conference on November 17
CRISPR Therapeutics stock is in focus ahead of a planned Jefferies healthcare conference appearance. Management will host a fireside chat.
ad-hoc-news.de, heute 03:43 Uhr
CRSP, CH0334081137
H.C. Wainwright reiterates USD 80.00 target for CRISPR Therapeutics ...
The Nasdaq quote was USD 49.88 after hours on October 20, 2026 in US trading. CRISPR Therapeutics stock costs EUR 44.46 on October 20, 2026.
ad-hoc-news.de, 20.10.26 22:03 Uhr
CRSP, CH0334081137
UBS sets a USD 52.00 target for CRISPR Therapeutics stock ...
Second-quarter revenue reached USD 10.18 million. CRISPR Therapeutics stock stood at USD 49.25 on October 16, 2026, down 4.41 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 21:42 Uhr
